Lee L A, Puhr N D, Maloney E K, Bean N H, Tauxe R V
Foodborne and Diarrheal Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333.
J Infect Dis. 1994 Jul;170(1):128-34. doi: 10.1093/infdis/170.1.128.
To assess factors associated with antimicrobial-resistant Salmonella infections and trends in resistance, a prospective study of patients with culture-confirmed salmonellosis was done in 1989-1990. Patients with resistant infections were more likely than those with susceptible infections to be hospitalized (P = .006), to be < 1 year old (P = .003), to be black (P = .013), and to have recently been treated with an antimicrobial agent (P = .085). Compared with data from a similar study in 1979-1980, increases were seen in the percentage of patients with resistant infections (from 17% to 31%), in the resistance to ampicillin (10% to 14%), and in the frequency of isolates found in blood (1% to 11%). These data show that treatment of Salmonella infections may be complicated by growing resistance to clinically important antimicrobial agents and by an increasing frequency of extraintestinal complications. Antimicrobial agents with little demonstrated resistance should be considered for patients with complicated illness and at high risk of having a resistant infection.
为评估与耐抗菌药物沙门氏菌感染相关的因素及耐药性趋势,于1989 - 1990年对培养确诊为沙门氏菌病的患者进行了一项前瞻性研究。与敏感感染患者相比,耐药感染患者更有可能住院(P = 0.006)、年龄小于1岁(P = 0.003)、为黑人(P = 0.013)以及近期接受过抗菌药物治疗(P = 0.085)。与1979 - 1980年类似研究的数据相比,耐药感染患者的百分比(从17%增至31%)、对氨苄西林的耐药性(从10%增至14%)以及血液中分离菌的频率(从1%增至11%)均有所增加。这些数据表明,沙门氏菌感染的治疗可能因对临床重要抗菌药物的耐药性增加以及肠外并发症频率上升而变得复杂。对于病情复杂且有耐药感染高风险的患者,应考虑使用耐药性较低的抗菌药物。